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Acetylcholine (ACh) is a major retinal neurotransmitter that modulates visual processing
through a large repertoire of cholinergic receptors expressed on different retinal cell
types. ACh is released from starburst amacrine cells (SACs) under scotopic conditions,
but its effects on cells of the rod pathway have not been investigated. Using whole-cell
patch clamp recordings in slices of rat retina, we found that ACh application triggers
GABA release onto rod bipolar (RB) cells. GABA was released from A17 amacrine cells
and activated postsynaptic GABAA and GABAC receptors in RB cells. The sensitivity
of ACh-induced currents to nicotinic ACh receptor (nAChR) antagonists (TMPH ∼
mecamylamine > erysodine > DhβE > MLA) together with the differential potency of
specific agonists to mimic ACh responses (cytisine >> RJR2403 ∼ choline), suggest that
A17 cells express heteromeric nAChRs containing the β4 subunit. Activation of nAChRs
induced GABA release after Ca2+ accumulation in A17 cell dendrites and varicosities
mediated by L-type voltage-gated calcium channels (VGCCs) and intracellular Ca2+ stores.
Inhibition of acetylcholinesterase depolarized A17 cells and increased spontaneous
inhibitory postsynaptic currents in RB cells, indicating that endogenous ACh enhances
GABAergic inhibition of RB cells. Moreover, injection of neostigmine or cytisine reduced
the b-wave of the scotopic flash electroretinogram (ERG), suggesting that cholinergic
modulation of GABA release controls RB cell activity in vivo. These results describe a
novel regulatory mechanism of RB cell inhibition and complement our understanding of
the neuromodulatory control of retinal signal processing.
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INTRODUCTION
Nicotinic acetylcholine receptors are widely distributed through-
out the central nervous system and play essential roles in learning,
cognition and addiction (Dani and Bertrand, 2007). Central
nAChRs are pentameric cationic channels assembled as homo-
mers of α7–α9 subunits or by combinations of α2–α6 and β2–β4
subunits (Millar and Gotti, 2009). This heterogeneity endows
nAChRs with different physiological and pharmacological prop-
erties and therefore diverse functional roles in neuronal networks
(Mansvelder et al., 2006; Dani and Bertrand, 2007; Albuquerque
et al., 2009).
In the mammalian retina, ACh is synthesized and released
from starburst amacrine cells (SACs) that form narrowly defined
cholinergic plexuses in the inner plexiform layer (IPL) (Voigt,
1986). Release of ACh may activate different classes of cholin-
ergic receptors present in bipolar, amacrine and ganglion cells
(AC and GCs) (Keyser et al., 2000; Dmitrieva et al., 2001, 2003,
Abbreviations: AC, amacrine cell; ACh, acetylcholine; CP-AMPAR, calcium per-
meable AMPA receptor; CICR, calcium induced calcium release; GC, ganglion
cell; IPL, inner plexiform layer; nAChR, nicotinic acetylcholine receptor; RB, rod
bipolar.
2007; Moretti et al., 2004; Marritt et al., 2005; Strang et al., 2010).
Indeed, functional nAChRs are expressed in GCs that stratify
close to SAC dendrites (Kittila and Massey, 1997; Fried et al.,
2005; Reed et al., 2005; Strang et al., 2007; Briggman et al., 2011)
as well as in cells whose processes are located far from these
cholinergic bands (Masland and Ames, 1976; Ariel and Daw,
1982; Schmidt et al., 1987; Strang et al., 2003, 2005). Activation
of nAChRs also modulates the ON bipolar cell-dependent b-wave
of the electroretinogram (ERG) (Jurklies et al., 1996; Varghese
et al., 2011; Moyano et al., 2013), suggesting that ACh may
influence signal transmission at stages preceding GC activation,
but its specific targets and mechanisms of action remain largely
unknown.
ACh release occurs under a broad range of illuminations
(Masland and Livingstone, 1976; Massey and Neal, 1978, 1979b;
O’Malley and Masland, 1993), including scotopic conditions
when luminous signals detected by rods are mainly processed by
the classic rod pathway. The first steps in this circuit involve the
sequential activation of two dedicated cell types, RB and AII-ACs.
The latter form chemical and electric synapses with cone bipo-
lar cells to convey rod signals to GCs (Bloomfield and Dacheux,
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2001; Wässle, 2004). Glutamate release from RB to AII cells
remains tightly controlled by numerous reciprocal GABAergic
synapses between A17 AC and RB cell axons (Hartveit, 1999;
Singer and Diamond, 2003; Chávez et al., 2006), providing stabil-
ity and enhanced temporal resolution at the RB-AII cell synapse
(Nakatsuka and Hamasaki, 1985; Dong and Hare, 2002a,b).
In the present study we analyzed the influence of ACh on signal
processing in the classic rod pathway. We have found that GABA
release from A17 cells can be elicited by activation of nAChRs and
that this modulation regulates RB cell activity, a new mechanism
by which retinal circuits shape visual responses under low light
conditions.
MATERIALS AND METHODS
All experiments were performed on 30–50 day-old Sprague
Dawley rats irrespective of sex. The rats, born and raised in the
animal facility of the University of Valparaiso (Animal Welfare
Assurance NIH A5823-01), were held at 20–25◦C under a 12 h
photoperiod with water and food ad libitum. The experimen-
tal procedures were approved by the bioethics committee of the
University of Valparaiso and in accordance with the bioethics
regulation of the Chilean Research Council (CONICYT).
ELECTROPHYSIOLOGY
After a period of dark adaptation (≥1 h), rats were decapitated
under deep anesthesia and their eyes were removed and sub-
merged in ACSF containing (mM) 119 NaCl, 23 NaHCO3, 1.25
NaH2PO4, 2.5 KCl, 2.5 CaCl2, 1.5 MgCl2, 20 Glucose, 2 Na-
Pyruvate, 1 ascorbic acid (bubbled with a mixture of 95% O2–5%
CO2). The retina was isolated and embedded in low melting
point agarose (3%), glued to a vibratome stage and sections of
∼200μm thickness were obtained. All slicing procedures were
performed under dim red light and sections were kept in the
dark at room temperature. Retinal slices were then transferred to
a recording chamber in which they were superfused with ACSF
1–2ml/min (∼30◦C) supplemented with strychnine (2μM) to
block glycine receptors. Cells were selected using a BX51WI
microscope (Olympus, Japan) placed in a light tight enclosure
and equipped with infrared differential interference contrast.
Patch pipettes were pulled from borosilicate glass and had resis-
tances of ∼5 or ∼10 M (for AC and RB cells recordings,
respectively) when filled with an intracellular solution contain-
ing (mM) 125 cesium-methanesulfonate, 10 HEPES, 5 EGTA,
6 Na2ATP, 0.4 GTP, 15 TEA-Cl, 1 MgSO4 (pH 7.4; osmolar-
ity ∼294 mOsm) and 1% Lucifer Yellow (Sigma Aldrich, St.
Louis, MO, USA) or Alexa Fluor 488 (Invitrogen, USA). Signals
were recorded using a PC-501A (Warner Instruments, Hamden,
USA) or an EPC7-plus (HEKA Elektronik, Lambrecht, Germany)
amplifier, digitized at 20 kHz (PCI-6221, National Instruments,
Austin, TX, USA) and stored using custom software written in
IGOR PRO (Wavemetrics, Lake Oswego, OR, USA). Series resis-
tance was below 20 or 30 M for AC and RB cells respectively,
and left uncompensated. Liquid junction potential was calcu-
lated to be 10mV and corrected off-line. ACs were kept at a
holding membrane potential (Vhold) of −60mV while IPSCs
in RB cells were recorded at 0mV. Cells were morphologically
identified at the end of the experiment using the fluorescence
image obtained with a digital camera (DS-MBWc, Nikon,
Japan).
CALCIUM IMAGING
To record calcium signals fromA17 cells, glass pipettes were front-
filled with normal intracellular solution and back-filled with the
same solution supplemented with the calcium indicator Oregon
Green 488 BAPTA-1 (OGB-1, 100–150μM, Molecular Probes,
Eugene, OR, USA). After ∼15min, images were obtained using a
CooLed illumination system (Cooledinc, Traverse City, MI, USA)
and a Sensicam QE digital camera (Cooke Corp., Romulus, MI,
USA). Data was acquired at 125Hz and analyzed using custom
software written in IGOR PRO.
ELECTRORETINOGRAPHY
Methods used for electroretinography have been described previ-
ously (Vielma et al., 2010). Briefly, animals were dark adapted for
2 h and anesthetized by halothane inhalation followed by injec-
tion of ketamine (40mg/kg) and xylazine (4mg/kg). Pupils were
dilated using atropine (1%) and lidocaine (1%) was used as a
topic anesthetic. Signals were recorded using a silver chloride ring
electrode on the cornea and a subcutaneous platinum electrode
in the eyelids as a reference. Animals were stimulated for 10ms
with a light spot of 1.5mm of diameter, illuminance of 1.9 log
scot cd s m−2 and wavelength of 500 nm. After recording control
responses, animals were injected with the tested drugs dissolved
in PBS using a 27-gauge needle through the ora serrata into the
vitreous. Drug concentrations in the eye were calculated consid-
ering an average vitreal volume of 0.15ml. ERG responses were
measured again after ∼10min. Rats were finally sacrificed by an
overdose of halothane.
DRUGS AND SOLUTIONS
ACh, choline, neostigmine, verapamil, nifedipine, 4-Chloro-
methyl-cresol, and ruthenium red were purchased from
Sigma (St. Louis, MO, USA). Mecamylamine, dihydro-β-
erythroidine, phenserine, TPMPA, SR95531, methyllycaconitine,
tetramethylpiperidine-4-yl-heptanoate, tetrodotoxin (TTX),
cyclopiazonic acid and strychnine were obtained from TOCRIS
(Bristol, UK). Erysodine and cytisine were synthesized and
kindly provided by Dr. Patricio Iturriaga from the Chemistry
department of the Universidad de Chile. All drugs were dis-
solved as stock solutions in bi-distilled water or DMSO, and
were diluted to the final concentration in control ACSF before
the experiment. For localized puff applications, agonists were
dissolved in HEPES-buffered ACSF in which NaHCO3 was
substituted for HEPES. Puffs were applied into the (IPL) from
glass pipettes with ∼1.5μm tip of inner diameter, using a
custom-built picospritzer with 5 psi standard pressure. Specific
nAChR agonists were loaded into one compartment of a puffer
pipette pulled from borosilicate theta glass (World precision
instruments, Sarasota, FL, USA) while the other was loaded
with ACh, achieving similar pressure ejection conditions for
both compounds. Puff applications were separated by 3–6min.
Drugs added to the bath were superfused for a minimum time
of 10min before evaluating its effects. In a subset of experi-
ments, tested drugs were washed-out (>30min) and recovery of
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responses from the treatment was evaluated (See Supplementary
Table 1).
DATA ANALYSIS
Data analysis was performed in IGOR PRO. Input resistance (Rin)
was obtained by measuring the inverse slope of a linear fit to the
current-voltage plots (10mV steps from −120 to −80mV). Peak
amplitude was measured after low-pass filtering at 1 kHz for elec-
trophysiological data or after filtering at 25Hz and subtraction
of background fluorescence for Ca2+ imaging signals. Electrical
charge moved during a response was calculated as the integral
of the baseline-subtracted response. Reversal potential of ACh
evoked currents was calculated as the intercept of a line-fit of the
peak amplitude values plotted against the corresponding Vhold.
Decay of evoked responses was fitted to a mono-exponential
function. Frequency of spontaneous postsynaptic currents was
quantified from 2–4min recordings obtained during control
conditions and immediately after arrival of the tested agents
using automatic detection algorithms andmanually reviewing the
obtained results (Mini Analysis, Synaptosoft Inc., Decatur, GA,
USA). Statistical analysis was performed using SigmaPlot (Systat
software). After evaluation for normality using Shapiro-Wilk nor-
mality test, statistical significance was evaluated using two-tailed
paired student’s t-test. In Figures 6E,F, significant differences
were tested using a repeated measures ANOVA and Bonferroni-
corrected paired comparisons. Except indicated, all experiments
were compared to their own control. For comparing multiple
treatments, a One-Way ANOVA or a Kruskal-Wallis One-Way
ANOVA on ranks on the normalized changes was used, fol-
lowed by post hoc pairwise comparison using Dunn’s method. In
Figures 1C, 3G, 4D, 5C, 6C bar plots represent percentage of con-
trol ± standard error. In Figures 6H,I and Figure S1G, bar plots
depict mean frequency± standard error. Circles in bar plots show
individual experiments. ∗indicates p < 0.05, ∗∗p < 0.01, and
∗∗∗p < 0.001. Traces were filtered at 100Hz for display purposes.
RESULTS
ACETYLCHOLINE INDUCES GABAERGIC SIGNALING ONTO RB CELLS
To study the influence of ACh on the rod pathway, we started
by performing voltage clamp experiments in RB cells. These cells
have their cell body generally located in the outer part of the INL
and show sustained inward currents upon depolarization largely
mediated by L-type VGCCs (Protti and Llano, 1998), allowing
confirmation of their identity under whole cell voltage clamp
(Figure 1A, right). Post hoc morphological examination revealed
the characteristic RB cell features (Chávez et al., 2006), an axon
traversing the entire IPL that narrowly extends axonal boutons
close to the GC layer (Figure 1A, left). Application of ACh (1mM,
1 s) to the middle of the IPL induced outward currents in all RB
cells tested (Vhold 0mV, n = 129), which had a reversal poten-
tial close to the Cl− equilibrium potential (ECl = −52.1mV,
Erev = − 54.5mV, n = 5, Figure 1B). Pharmacological analysis
revealed that ACh-evoked currents were generated by the acti-
vation of GABAA (77 ± 6% of control amplitude after SR95531
10μM, n = 12, p = 0.008) and GABAC receptors (29 ± 3.3% of
control after TPMPA 50μM, n = 10, p = 0.0025; 6.2 ±1.4% of
control with SR95531 and TPMPA combined, n = 8, p = 0.005,
FIGURE 1 | ACh induces GABA release from A17 cells onto rod bipolar
cells. (A) Left, image of a rod bipolar (RB) cell filled with Lucifer yellow
during whole-cell patch clamp recordings. Scale bar indicates 10μm. Right
top, current responses from the cell in the left to voltage steps from −60 to
−100, −20 (red trace) and 40mV. Right bottom, current-voltage relationship
for the same cell (10mV voltage steps from −120 to 40mV). (B) Left,
representative current responses of RB cells to puff applications of ACh
(1mM, 1 s) at different holding potentials. Right, normalized amplitude of
ACh responses in RB cells plotted against the holding potential (n = 4).
(C) Traces showing the effect of GABAC receptor–specific antagonist
TPMPA (50μM) and GABAA antagonist SR95531 (SR, 10μM) on
ACh-evoked IPSCs in RB cells. (Vhold = 0mV). Right, bar plot summarizes
the effect of both GABA receptor antagonists applied separately or
combined on ACh-induced responses. (D) Traces depict the lack of effect of
AMPA/Kainate receptor antagonist application (NBQX 5μM) in ACh-induced
IPSCs (see text). Two-tailed paired t-test, ∗∗p < 0.01.
Figure 1C). Blocking AMPA and kainate receptors did not have a
significant effect on the responses to ACh (NBQX 5μM, 94.2 ±
2.9% of control, n = 5, p = 0.2, Figure 1D), suggesting they were
generated by direct cholinergic activation of ACs presynaptic to
RB cells.
A17 CELLS MEDIATE ACh-INDUCED GABA RELEASE ONTO RB CELLS
Although RB cells receive inputs from different GABAergic ACs,
almost half of their inhibitory axonal contacts are reciprocal
synapses with A17 cells (Strettoi et al., 1990; Kim et al., 1998).
Therefore, we tested the possibility that these ACs generated the
GABAergic IPSCs evoked by ACh in RB cells. A17 cells were
selected in retinal slices by aiming at large oval-shaped cell bodies
located in the inner part of the inner nuclear layer. During voltage
clamp recordings, the low input resistance (224 ± 11 M, n =
99) and nearly linear current-voltage relationship (Figure 2A,
bottom) of A17 cells provided a reliable indicator of cell identity.
Fluorescent images confirmed our physiological identification
and showed the main morphological properties of A17 cells
(Menger and Wässle, 2000), namely the presence of multiple
thin dendrites bearing varicosities that radially extend toward the
GCL border (Figure 2A). In all A17 cells tested, pulsed applica-
tions of ACh to the IPL induced strong inward currents (average
amplitude −215 ± 12 pA, Vhold − 60mV, n = 98, Figure 2B)
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and a mean depolarization of 33.6 ± 3.7mV in current clamp
recordings (n = 5, membrane resting potential −61.6 ± 1mV,
Figure 2B, inset). Currents evoked by ACh reversed at 5.5mV
(n = 4; Figure 2B, right) and were insensitive to synaptic block
by divalent VGCC blockers (100.9 ± 5.7% of control response
with Cd2+ 200μM, n = 5, p = 1, Figure 2B left; 98.7 ± 4.1% of
control with Co2+ 1mM, n = 4, p = 0.65, Figure S1A) or inhi-
bition of AMPA/kainate receptors (NBQX 5μM, 116.5 ± 8.6%,
n = 3, p = 0.42, Figure S1B), demonstrating their postsynaptic
origin. ACh-evoked responses only mildly desensitize at the con-
centrations tested, as shown by the fact that a second application
of ACh after a 2 s interval triggered currents with an amplitude of
56.5 ± 6.6% of the control response (n = 3; Figure 2C).
Interestingly, other populations of ACs also displayed inward
currents when either ACh or nicotine was applied (69 out of
206 non-A17 ACs tested, data not shown). These cells formed
a heterogeneous population displaying different morphological
and physiological properties indicating that cholinergic mod-
ulation of inhibition is a widespread phenomenon in the rat
retina. However, isolation of GABAergic IPSCs from A17 onto
RB cells with TTX (1μM, Chávez et al., 2006) left postsy-
naptic ACh responses unchanged (93 ± 12% of control, p =
0.2, n = 6; Figure 2D). In summary, we have found that ACh-
evoked GABAergic IPSCs in RB cells are mostly generated by
GABA released from A17 cells after the activation of functional
cholinergic receptors.
FIGURE 2 | Depolarization of A17 cells mediates acetylcholine evoked
IPSCs in RB cells. (A) top, image of an A17 cell filled with Lucifer yellow
during whole-cell patch clamp. Scale bar indicates 10μm. Bottom, (left)
responses of the A17 cell to voltage steps from −100 to 20mV (20mV
steps) and (right) plot of its current-voltage relationship. (B) Representative
trace of ACh-evoked currents in A17 cells (Vhold − 60mV) which were
unaffected by calcium channel blockage with Cd2+ (200μM). Inset shows
the response of an A17 cell to ACh in current clamp mode. Right,
normalized amplitude of ACh responses in A17 cells plotted against holding
potential (n = 4). (C) Summary of paired responses to ACh (1mM, 100ms)
with different inter-stimulus intervals. Inset shows the response to a paired
stimulus separated by 2 s. (D) ACh-evoked IPSCs in rod bipolar cells were
insensitive to perfusion of tetrodotoxin (TTX 1μM, n = 7) suggesting that
GABA is released from A17 cells (Chávez et al., 2010).
PHARMACOLOGY OF A17 CELL nAChRs
ACh is the natural agonist of metabotropic and ionotropic cholin-
ergic receptors. Given that both can be found in the mammalian
retina (Wassélius et al., 1998; Keyser et al., 2000; Marritt et al.,
2005), we asked which of these receptor types mediates the release
of GABA from A17 cells. In agreement with their cationic nature,
ACh-induced currents in A17 cells were effectively reduced by
the general nAChR antagonist mecamylamine (Mec 2μM, 15.4±
1.5% of control, n = 17, p = 0.00004) but unaffected by the mus-
carinic antagonist scopolamine (Sco 10μM, 107.4 ± 12.4% of
control, n = 4, p = 0.58; Figures 3A,B left, G). Moreover, nico-
tine also effectively elicited inward currents in A17 cells (Nicotine
1mM, 500ms, −199.6 ± 33 pA, n = 10, Figure 5D, middle).
Consequently, IPSCs evoked after ACh application in RB cells
were completely abolished by mecamylamine (6.7 ± 3.6% of
FIGURE 3 | Heteromeric nAChRs cells mediate ACh responses in A17
and RB cells. (A–F) Representative traces of current responses induced by
localized puffs of ACh (1mM, 1 s) at the IPL in A17 (left) and in RB cells
(right) in control conditions and in the presence of (A) the nicotinic receptor
blocker mecamylamine (Mec 2μM), (B) muscarinic receptor antagonist
scopolamine (Sco 10μM), (C) heteromeric nAChR antagonist
tetramethylpiperidine-4-yl-heptanoate (TMPH 10μM), (D) homomeric
nAChR antagonist methylcaconitine (MLA 10nM) or α4β2antagonists (E)
dihydro-β-erythroiodine (DHβE 10μM) and (F) erysodine (Ery 10μM).
Vertical scale bars represent 50 pA for A17 cell responses and 5 pA for RB
cell traces, and horizontal bars depict 1 s of time. (G) Bar graph
summarizing the effects of cholinergic receptor antagonists on the
ACh-induced currents in A17 (gray bars) and RB cells (white bars).
Two-tailed paired t-tests, ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001. For A17
cells, significant differences were observed between Mec and TMPH if
tested vs. the effects of Sco, MLA or DHβE. For RB cells, differences were
significant when comparing the influence of Mec and TMPH vs. Sco or
MLA (One-Way ANOVA on ranks and Dunn’s method for multiple
comparisons).
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control, n = 4, p = 0.04) while scopolamine had no significant
effect (94.8± 9.9% of control, n = 6, p = 0.9; Figures 3A,B right,
G). Thus, A17 cells of the rat retina express functional nAChRs.
Nicotinic receptors are assembled by different combina-
tions of α and β subunits. The precise subunit composition
defines important receptor properties such as ligand affin-
ity, channel kinetics and ionic selectivity (Alkondon and
Albuquerque, 1993), greatly affecting the influence that nAChR
activation will have in cellular function. To investigate which
nAChR subtypes are expressed in A17 cells and mediate
postsynaptic responses in RB cells, we tested the effects
of specific nicotinic pharmacological agents. Perfusion of
an antagonist specific for neuronal heteromeric nAChRs
(tetramethylpiperidine-4-yl-heptanoate [TMPH] 10μM, Damaj
et al., 2005; Papke et al., 2005) abolished ACh responses in
both cell types (3.6 ± 0.7% of control in A17 cells, n = 5,
p = 0.02; 3.2 ± 0.4% of control in RB cells, p = 0.008, n =
5, Figures 3C,G), while homomeric nAChR-specific antagonist
methyllycaconitine (MLA) did not produce a significant effect
neither in A17 nor in RB cells (10 nM; 96.8 ± 4.2 and 96.7 ±
2.7% of control responses, p = 0.25 and 0.17 respectively, n = 8
for both cells types, Figures 3D,G). One of the most commonly
expressed heteromeric nAChRs in the CNS is the α4β2 sub-
type (Dani and Bertrand, 2007). The prototypical α4β2 nAChR
antagonist dihydro-β-erythroiodine (DHβE 10μM, Harvey et al.,
1996) produced a small albeit significant reduction of ACh-
induced currents in A17 cells (89.7 ± 3% of control, n = 15, p =
0.009) and a marked decrease in RB cell responses (61 ± 5.3%
of control, n = 6, p = 0.003; Figures 3E,G). Erysodine (10μM),
another alkaloid with high affinity for α4β2 nAChRs (Decker and
Anderson, 1995; Iturriaga-Vásquez et al., 2010), had a more pro-
nounced effect in A17 and RB cells (36.1 ± 3.3% of control in
A17 cells, n = 10, p = 0.0002; 17 ± 0.8% of control in RB cells,
n = 10, p = 0.00003; Figures 3F,G) but did not completely block
the response to ACh. Pharmacology of nicotinic receptors in A17
cells was further investigated by comparing ACh-evoked currents
with those induced by specific nicotinic agonists. Choline (Chol,
1mM), a byproduct of ACh cleavage and an α7-nAChR-specific
ligand (Alkondon and Pereira, 1999), produced only a marginal
response in A17 cells and had no discernible effect in RB cells
(10.1 ± 3.9 and 2.5 ± 2% of ACh-evoked responses respectively,
n = 5 for both cell types, p = 0.03 and 0.017; Figures 4A,D).
Likewise, an agonist with specificity for α4β2 nAChRs (RJR-2403
100μM, Papke et al., 2000) failed to activate either A17 or RB
cells (7.5 ± 5% and 1.7 ± 0.6% of ACh response, n = 4 and 3,
p = 0.009 and 0.004, respectively; Figures 4B,D). On the con-
trary, the β4 subunit-specific nicotinic agonist cytisine (100μM;
Luetje and Patrick, 1991; Papke and Heinemann, 1994) induced
currents in A17 and RB cells comparable to those evoked by ACh
(108.7 ± 14.7% and 113.3 ± 22.1% of ACh responses respec-
tively, n = 5 for both cell types, p = 0.58 and 0.97; Figures 4C,D),
although with a slower decay (tau 3.9 ± 0.3 vs. 28.7 ± 4.9 s, for
ACh vs. cytisine-evoked currents in A17 cells, n = 5, p = 0.047).
In summary, ACh responses in both cell types have a compa-
rable pharmacological profile, further supporting that A17 cells
through activation of heteromeric nAChRs, provide the majority
of the ACh-triggered GABA release onto RB cells.
FIGURE 4 | Functional β4-containing nAChRs are expressed in A17 cells
and mediate ACh-evoked GABA release onto RB cells. Representative
traces of whole-voltage clamp recordings during localized application of
ACh (1mM, 1 s) or nicotinic agonists specific for (A) homomeric (choline
1mM, 1 s, top), (B) α4β2(RJR-2403 100μM, 1 s, middle) or (C) β4
subunit-containing nAChRs (cytisine 100μM, 1 s, bottom) in A17 (top) or RB
cells (bottom). All experiments were performed using double-barreled
puffer pipettes. (D) Bar plot summarizing the normalized effects of specific
nicotinic agonists on A17 (gray solid bars) and RB (with bars) cells.
Two-tailed paired t-test, ∗p < 0.05 and ∗∗p < 0.01. The normalized average
effect of cytisine was significantly different when compared to choline or
RJR-2403 in A17 (One-Way ANOVA with Bonferroni-adjusted pairwise
comparisons) and RB cells (One-Way ANOVA on ranks with post hoc
Dunn’s test).
MECHANISMS OF ACh-EVOKED GABA RELEASE
Next, we investigated the mechanisms through which nAChR
activation induces Ca2+ entry into A17 cells, by studying ACh-
evoked IPSCs in RB cells. Perfusion with Ca2+-free solutions
importantly reduced the amplitude of ACh-evoked IPSCs in RB
cells (0 Ca2+, 29.5± 6% of control, n = 4, p = 0.015, Figures 5A
left, C; 0 Ca2+ + 1mM EGTA, 25.3 ± 5.2% of control, n = 4,
p = 0.003, Figures S1C, 5C). Because heteromeric nAChRs form
channels with relatively low Ca2+ permeability (Fucile, 2004),
Ca2+ influx should be provided by a different membrane conduc-
tance. Indeed, general blockers of VGCCs effectively reduced the
response of RB cells to ACh (Cd2+ 200μM, 14.5 ± 2.8% of con-
trol, n = 9, p = 0.001, Figures 5Amiddle, C; Co2+ 1mM, 19.5±
1.2% of control, n = 4, p = 0.01, Figures S1D, 5C). More specifi-
cally, inhibition of L-type VGCCs, which are known to be present
in synaptic varicosities of A17 cells (Grimes et al., 2009), almost
completely abolished ACh responses (verapamil 20μM, 7.3 ±
1.4% of control, n = 5, p = 0.02, Figures 5A right, C; nifedip-
ine 30μM, 17± 3.7% of control, n = 5, p = 0.0007, Figures S1E,
5C). This indicates a prevalent role of L-type VGCCs in cholin-
ergic release of GABA from A17 cells, contrary to their limited
participation when glutamate is the excitatory neurotransmitter
(verapamil 20μM, 91.8± 4.1% of control responses to glutamate
Frontiers in Cellular Neuroscience www.frontiersin.org February 2015 | Volume 9 | Article 6 | 5
Elgueta et al. Acetylcholine enhances rod bipolar inhibition
FIGURE 5 | Mechanisms of ACh-induced GABA release from A17 cells.
(A) Representative traces of ACh-evoked IPSCs in RB cells (1mM, 1 s) in
control conditions and after (left) removing extracellular Ca2+, (middle)
applying the unspecific VGCC blocker Cd2+ (200μM) or (right) after specific
blockade of L-type VGCCs with verapamil (20μM). (B) Traces showing the
effects of disrupting intracellular calcium signaling by (left) a blocker of
ryanodine receptor channels (ruthenium red, RR 40μM), (middle) an
inhibitor of the endoplasmic reticulum Ca2+-ATPase pump (cyclopiazonic
acid, CPA 30μM) and (right) an agonist of ryanodine receptors
(4-chloro-m-cresol, 4-CMC 500μM) on the responses to ACh in RB cells.
(C) Bar graph displaying normalized average ACh response amplitudes in
RB cells after perfusion with solutions affecting presynaptic calcium
dynamics. ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001, for two-tailed paired
t-tests. Differences between groups were significant when verapamil was
compared with CPA or 4-CMC, and when Cd2+ is compared with 4-CMC
(One-Way ANOVA on ranks with post hoc Dunn’s test). (D) Left, montage
of images from an A17 cell filled with 100μM OGB-1 (scale bar 10μm).
Analyzed regions of interest are denoted by colored frames and correspond
to Ca2+ responses traces after (middle) puff application of nicotine (Nic
1mM, 500ms) or (right) after a 60mV voltage step of 200ms duration.
Bottom, black traces show current responses after the respective
stimulation paradigms.
[200μM, 200ms], n = 3, Figure S1F; see also Chávez et al., 2006;
Grimes et al., 2009). On the other hand, Ca2+-induced Ca2+
release (CICR) from intracellular stores could also contribute by
enhancing the cytoplasmatic Ca2+ concentration after an initial
influx of the ion, as reported for glutamate-evoked GABA release
from A17 cells (Chávez et al., 2006; Chávez and Diamond, 2008).
Indeed, perfusion with an antagonist of ryanodine receptors
produced a significant decrease in the amplitude of IPSCs
triggered by ACh (ruthenium red, RR 40μM, 26.7 ± 3%
of control, n = 5, p = 0.002; Figures 5B left, C). Consistently,
depletion of Ca2+ from the endoplasmic reticulum using the
Ca2+-ATPase antagonist cyclopiazonic acid (CPA 30μM) or
the ryanodine receptors agonist 4-chloro-methyl-cresol (4-CMC
500μM) significantly diminished IPSCs evoked by ACh in RB
cells (35.5 ± 5.6% and 50.4 ± 6.3% of control response,
p = 0.043 and 0.049, respectively, n = 4 for both conditions;
Figures 5B,C).
To further confirm that activation of nAChRs induced Ca2+
accumulation in these ACs, we loaded A17 cells with the high
affinity Ca2+-sensitive dye OGB-1, and imaged the response to
nicotine puff applications. Nicotine generated strong and long
lasting calcium signals (Figure 5D) that were significantly larger
when measured at regions of interest that included dendritic vari-
cosities compared to portions devoid of them (F/F = 42 ± 9.4
vs. 23.7 ± 8.2%, n = 9, p = 0.004; Figure 5D, middle). Nicotine-
induced calcium transients were similar in amplitude to those
evoked by a depolarization step (60mV, 200ms, 44.8 ± 14.8 vs.
46.2 ± 8.9% of F/F, n = 5, Figure 5D, right), indicating that
activation of nAChRs has a strong depolarizing effect.
Altogether, these findings support the notion that nAChR-
mediated depolarization of A17 cells activates L-type VGCCs and
CICR, resulting in Ca2+ accumulation that finally drives GABA
release onto RB cells.
GABA RELEASE FROM A17 CELLS IS MODULATED BY ENDOGENOUS
ACh IN VITRO AND IN VIVO
Although we have demonstrated that ACh application has impor-
tant effects on GABAergic inputs to RB cells, it remains to be
shown whether endogenous ACh is able to modulate A17-RB
cell signaling. For this purpose we analyzed the effects of acetyl-
cholinesterase (AChE) inhibitors on A17 and RB cell activity.
Perfusion with neostigmine or phenserine induced a marked
increase in the electrical charge moved during ACh-induced
responses in A17 (neostigmine 2μM, 641 ± 114% of control,
n = 7, p = 0.005; phenserine 5μM, 262 ± 22%, n = 4, p =
0.039, Figures 6A,C) and RB cells (neostigmine 2μM, 698.8 ±
197%, n = 10, p = 0.0005, Figures 6B,C), demonstrating that
AChE actively cleaves ACh in rat retinal slices. Interestingly,
application of neostigmine alone was able to significantly depo-
larize A17 cells (neostigmine 2μM, from−61.4 ± 0.9 to−53.2 ±
1.8mV, n = 5, p = 0.0041). This depolarization was mediated
by nAChR activation as it was reversed to near-control val-
ues by subsequent perfusion with TMPH (neostigmine 2μM +
TMPH 10μM, −60.4 ± 1.2mV, n = 3, p = 0.01, Figures 6D,E).
Similarly, during voltage-clamp recordings from a different set
of cells, AChE inhibitors induced long-lasting inward currents
(neostigmine 2μM, from 12.5 ± 11.8 pA to −20.5 ± 11.9 pA,
n = 7, p = 0.012; phenserine 5μM, 0.8 ± 7.1 pA to −24.9 ± 5.9
pA, n = 5, p = 0.04, Figure 6F). The observed effects of AChE
inhibitors were not accompanied by an apparent increase in
EPSC frequency, suggesting that nAChRs in A17 cells might be
non-synaptically activated. Indeed, the frequency of spontaneous
EPSCs during inhibition of AMPA/Kainate receptors (NBQX
5μM) did not change after perfusion of a specific nicotinic
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FIGURE 6 | Endogenous ACh enhances GABA release from A17 cells and
increases inhibition in RB cells. (A,B) Traces show the effect of the AChE
inhibitor neostigmine (Neo, 2μM) on responses to ACh (1mM, 1 s) in (A) A17
cells and (B) RB cells. (C) Bar plot summing up the effects of neostigmine or
phenserine (Phen, 5μM) application on the electrical charge transferred after
ACh stimulation. (D) In A17 cells, perfusion of neostigmine (2μM) produced a
long lasting depolarization that could be reverted by blocking nAChRs with
TMPH (10μM). Horizontal bars below traces show duration of both
treatments. (E) Summary of the changes in resting membrane potential
induced by an initial perfusion of Neo and subsequent addition of TMPH.
(F) In a different subset of A17 cells, the holding current (Vhold = −60mV)
was measured in control conditions, after adding AChE inhibitors Neo or
Phen, and after TMPH application. Thin lines denote individual cells and thick
lines display average values. Gray lines correspond to experiments with Phen,
black lines show experiments using Neo. (G) representative traces showing
the increase in the frequency of spontaneous IPSCs after neostigmine
perfusion in RB cells. (H) Bar plot summarizing the enhancement in IPSC
frequency by Neo. (I) Summary plot showing the marked increase in
frequency of IPSCs after perfusion of nicotine (25μM) in the presence of TTX
(1μM). ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001. Two-tailed paired t-tests
were used, except in panels E, F (Phenserine) where repeated measures
ANOVA followed by Bonferroni-corrected pairwise comparison was used.
FIGURE 7 | Activation of nicotinic receptors reduces the rod
bipolar-driven b-wave of the scotopic electroretinogram. (A,B)
representative traces of the scotopic flash ERG response in control
conditions and after intravitreal injection of (A) neostigmine (25μM) or (B)
the specific nAChR agonist cytisine (500μM). (C) Bar graph showing
average changes in the scotopic ERG a- and b-waves after neostigmine or
cytisine injections. Two-tailed paired t-test, ∗p < 0.05 and ∗∗p < 0.01.
antagonist (0.54 ± 0.18Hz during NBQX vs. 0.6 ± 0.3Hz after
TMPH + NBQX, n = 4, p = 0.63, Figure S1G), showing the
absence of spontaneous nAChR-mediated synaptic events in A17
cells. In RB cells neostigmine increased the frequency of sponta-
neous IPSCs about 5 fold (from 0.8 ± 0.1 to 3.5 ± 0.2Hz, n = 4,
p = 0.0008, Figures 6G,H). A similar result could be observed
when low concentrations of nicotine were applied in the presence
of TTX (Nicotine 25μM, from 1.2 ± 0.4 to 6.4 ± 2Hz, n = 5,
p = 0.047, Figure 6I) indicating that these enhancements in IPSC
frequency by nicotine and neostigmine are caused by increased
GABA release from A17 cells. In summary, these results demon-
strate that in the slice preparation under scotopic conditions, ACh
is intrinsically released reaching concentrations which are high
enough to depolarize A17 cells and boost synaptic GABAergic
neurotransmission.
Finally, we analyzed how the increase in GABAergic signal-
ing mediated by ACh and nAChRs affects light responses of RB
cells. We addressed this question using the in vivo scotopic flash-
evoked ERG. Intravitreal injection of neostigmine produced a
marked decrease in the ERG b-wave amplitude (Neo 25μM,
51.5 ± 7.7% of control, n = 5, p = 0.005), which mainly rep-
resents RB cell depolarization (Weymouth and Vingrys, 2008),
without significantly altering the photoreceptor-mediated a-wave
(83.3 ± 9.5% of control, n = 5; Figures 7A,C). Similarly, injec-
tion of cytisine produced a significant reduction in the b-wave
(cytisine 500μM, 64.1 ± 1.8, n = 3, p = 0.006; Figures 7B,C)
and a non-significant decrease in the a-wave (p = 0.199). This
indicates that ACh modulates RB cell light responses in vivo
through the activation of nAChRs.
DISCUSSION
Neuronal activity in the inner retina is shaped by a wide vari-
ety of GABAergic and glycinergic ACs, which form numerous
inhibitory synapses with bipolar and GCs, and provide feed-
back and feed-forward inhibition to the inner retinal circuitry
(Macneil and Masland, 1998; Wässle, 2004; Masland, 2012). The
overall excitability of the network is also under the influence of
neuromodulators acting on different types of cells in a slower
time scale, enhancing the flexibility of the system (Marc, 2004;
Witkovsky, 2004; Huang et al., 2013). RB cell output is controlled
by a diverse and heterogeneous set of inhibitory inputs (Eggers
and Lukasiewicz, 2006; Eggers et al., 2007; Chávez and Diamond,
2008; Chávez et al., 2010), but reciprocal synapses with A17 cells
(Hartveit, 1999; Singer and Diamond, 2003; Chávez et al., 2006)
are the most numerous (Strettoi et al., 1990; Kim et al., 1998).
The present study describes a novel modulatory mechanism of
A17 cell activity mediated by ACh and heteromeric nAChRs.
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SUBUNIT COMPOSITION OF nAChRs IN A17 CELLS
Nicotinic receptors comprise a heterogeneous family formed by
different combinations of α and β subunits (Dani and Bertrand,
2007; Millar and Gotti, 2009). Biochemical evidence suggests that
retinal nAChRs are assembled as complex combinations of α2–
α6 and β2–β4 subunits (Moretti et al., 2004; Marritt et al., 2005).
Using pharmacological agents which are subunit-specific at the
concentrations used (Alkondon and Albuquerque, 1993; Harvey
and Luetje, 1996; Papke et al., 2000), we demonstrate here that
A17 cells do not express the commonly found α7 or α4β2 nAChRs.
Instead, the strong response to the agonist cytisine (Alkondon
and Albuquerque, 1993; Papke and Heinemann, 1993; Takeda
et al., 2003; Smith and Uteshev, 2008) as well as the complete
block exerted by TMPH (Decker and Anderson, 1995; Damaj
et al., 2005; Papke et al., 2005) suggest that these nAChRs con-
tain the β4 subunit. Particularly, the low efficacy of DHβE in
blocking ACh-induced currents and the failure of RJR-2403 to
evoke responses in A17 or RB cells, indicate that nAChRs in A17
amacrine cells might be of the α3β4 subtype (Harvey and Luetje,
1996; Papke et al., 2000). This pharmacological characterization
is further supported by immunohistochemical data that failed to
demonstrate α3β2 or α7 nAChRs in rabbit A17-homologous cells
(Keyser et al., 2000; Dmitrieva et al., 2007, 2003). Finally, nAChRs
mediating ACh-evoked responses in A17 cells had low Ca2+ per-
meability and showed slow kinetics and weak desensitization
(Figures 2, 5), in agreement with the properties of β4 subunit-
containing nAChR channels (Papke and Heinemann, 1994; Quick
et al., 1999; Takeda et al., 2003; Fucile, 2004). Therefore, our
data are consistent with the interpretation that A17 cells of the
rat retina express heteromeric nAChRs that contain the β4 sub-
unit, although further experiments are necessary to determine
the exact composition of these receptors. Interestingly, the phar-
macology of Ach-induced GABA release into RB cells closely
resembles that of inward currents observe in A17 AC, support-
ing their prevalence in this modulatory mechanism. Nevertheless,
GABA release wasmore affected by nicotinic antagonists than A17
cell ACh-induced inward currents (Figure 3) and less sensitive to
agonists (Figure 4), suggesting that a minimum depolarization of
A17 terminals by ACh is required to trigger synaptic release.
MECHANISM OF ACh-INDUCED INHIBITION OF RB CELLS
Reciprocal feedback to RB cells depends on calcium flow through
Ca2+-permeable AMPA receptors (CP-AMPARs) and postsynap-
tic GABAA receptors (Singer and Diamond, 2003; Chávez et al.,
2006, 2010). BK channels present in A17 cell varicosities curtail
CP-AMPAR-mediated depolarization and limit L-type VGCCs
involvement in GABA release (Grimes et al., 2009). Nevertheless,
strong or long-lasting glutamate drive depolarizes A17 cells suf-
ficiently to overcome BK channel inhibition and engage VGCCs
in release events (Grimes et al., 2009) that activate both GABA
receptor subtypes (Hartveit, 1999; Dong and Hare, 2002a,b;
Singer and Diamond, 2003; Eggers et al., 2007; Chávez et al.,
2010). NAChRs can influence neurotransmitter release through
a variety of mechanisms, including direct Ca2+ influx through
the channel, recruitment of VGCCs by membrane depolariza-
tion or through intracellular Ca2+ release (Vizi and Lendvai,
1999; Dajas-Bailador and Wonnacott, 2004). We have shown
that ACh-induced GABA release in A17 cells is mainly medi-
ated by L-type VGCCs and CICR (Figure 5) and preferentially
activates GABAC receptors on RB cells (Figure 1). Cholinergic
recruitment of VGCCs in A17 cells will be facilitated by the low
Ca2+ permeability (avoiding early activation of BK channels) and
slow kinetics of A17 nAChRs. Interestingly, these previous obser-
vations suggest a correlation between VGCCs-mediated Ca2+
entry in A17 cells and postsynaptic GABACreceptors. Considering
that GABAAand GABAC receptors are spatially segregated in the
RB cell axon (Fletcher et al., 1998; Koulen et al., 1998; Chávez
et al., 2010), it is tempting to hypothesize that there are dif-
ferent classes of release sites within A17 cells and that ACh
induces GABA release preferentially from those presynaptic to
GABAC receptors. Our measurements showed that Ca2+ signals
evoked by ACh were stronger in regions containing varicosi-
ties, following the distribution of L-type VGCCs in A17 cells
(Grimes et al., 2009). It would be interesting to analyze the
subcellular localization of nAChRs in A17 cells in relation to
VGCCs and postsynaptic GABA receptors to better understand
the mechanisms of action of this nicotinic modulation of retinal
GABAergic signaling.
CHOLINERGIC MODULATION OF RB CELL GABAERGIC INHIBITION
In the mammalian retina, under photopic and scotopic con-
ditions, ACh is released both tonically and in a light-induced
manner (Masland and Livingstone, 1976; Massey and Neal, 1978,
1979a,b; Masland et al., 1984; O’Malley and Masland, 1993).
Although currently the in vivo dynamics of ACh activation of
A17 cells are unknown, our results support a system especially
suited for sustained control of GABA release. Namely, nAChRs
with sluggish kinetics gate slowly inactivating L-type VGCCs,
inducing GABA release that binds preferentially high-affinity and
slow GABAC receptors. Indeed, our data shows that the dura-
tion of nAChR-induced depolarization of A17 cells and GABA
release onto RB cells was mainly controlled by ACh availabil-
ity and AChE activity (Figure 6), demonstrating that ACh can
control RB cell activity on a slow time scale. Moreover, the
lack of nAChR-mediated synaptic events suggests that activa-
tion of A17 nicotinic receptors occurs extrasynaptically, a com-
mon mechanism for cholinergic neurotransmission in the CNS
that enables long-lasting modulation of synaptic activity (Dani
and Bertrand, 2007; Lawrence, 2008; Lendvai and Vizi, 2008;
Arroyo et al., 2014). In the retina, fast synaptic nAChR acti-
vation could be expected for cells directly connected to SAC
output (Brown and Masland, 1999; Yamada et al., 2003; Dong
et al., 2004; Fried et al., 2005), but ACh also influences GCs
that do not make synaptic contacts with SACs (Ames and Pollen,
1969; Masland and Ames, 1976; Ariel and Daw, 1982; Strang
et al., 2003, 2005). This suggests that volume release of ACh is
an important mode of cholinergic transmission in the retina,
as it is for the dopaminergic (Puopolo et al., 2001), melatonin-
ergic (Huang et al., 2013) and nitrergic systems (Vielma et al.,
2012). On the other hand, injection of AChE inhibitors into
the rat vitreous reduced the b-wave of the scotopic flash ERG
response in the rat, probably due to an enhanced activation
of nAChRs, as it could be partially replicated by injection of
a specific agonist (Figure 7). This result is in agreement with
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the observed effects of nicotine in humans (Jurklies et al., 1996;
Varghese et al., 2011) and shows that activity of bipolar cells
is actively modulated by nAChRs in vivo, although the exact
nature and dynamic properties of this modulation require further
assessment.
CONCLUSION
We are still far from understanding the complexities of the retinal
cholinergic neurotransmitter system as the functional relevance
of the widespread expression of cholinergic receptors has been
elusive, with the notable exceptions of ACh effects on direction-
selective GCs (Grzywacz et al., 1998; Fried et al., 2005; Reed
et al., 2005) and during development (Feller, 2002). This study
demonstrates that in the adult rat retina, ACh is a major player in
the regulation of GABAergic inhibition of RB cells. We hypothe-
size that non-synaptic nAChR activation slowly depolarizes A17
cells, which facilitates GABA release via L-type VGCCs enhanc-
ing its gain control function of the RB-AII cell synapse (Dong
and Hare, 2002a,b). This cholinergic control provides A17 cells
with a modulatory system independent from the activity of RB
cells, their main excitatory input and exclusive output, an advan-
tageous situation that would greatly improve the adaptability and
computational capabilities of A17 amacrine cells.
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